What are the risks of investing in SUPN?
S
What are the risks of investing in SUPN?
🦉
Supernus Pharmaceuticals, Inc. (SUPN)
Company Overview
Sector / IndustryHealthcare / Drug Manufacturers - Specialty & Generic
CEOJack A. Khattar
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for...
Key Executives
| Name | Title |
|---|---|
| Bryan A. Roecklein | Senior VP & Chief Business Officer |
| Frank Mottola | Senior Vice President & Chief Technology Operations Officer |
| Jack A. Khattar | Founder, President, Chief Executive Officer, Secretary & Director |
| Jeff Bozick | Senior Vice President of Supply Chain |
| Jonathan Rubin | Senior Vice President of Research & Development and Chief Medical Officer |
| Kevin T. Anderson | Compliance Officer |
Financial Health
Risk Assessment
Weather Score0/100
RegimeN/A